Austerberry James I, Belton Daniel J
Manchester Institute of Biotechnology, University of Manchester, 121 Princess Street, Manchester, M1 7DN, UK.
Department of Chemical Sciences, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH, UK.
3 Biotech. 2016 Jun;6(1):33. doi: 10.1007/s13205-015-0345-y. Epub 2016 Jan 14.
Large-scale expression of biopharmaceutical proteins in cellular hosts results in production of large insoluble mass aggregates. In order to generate functional product, these aggregates require further processing through refolding with denaturant, a process in itself that can result in aggregation. Using a model folding protein, cytochrome C, we show how an increase in final denaturant concentration decreases the propensity of the protein to aggregate during refolding. Using polarised fluorescence anisotropy, we show how reduced levels of aggregation can be achieved by increasing the period of time the protein remains flexible during refolding, mediated through dilution ratios. This highlights the relationship between the flexibility of a protein and its propensity to aggregate. We attribute this behaviour to the preferential urea-residue interaction, over self-association between molecules.
生物制药蛋白在细胞宿主中的大规模表达会导致产生大量不溶性聚集体。为了生成功能性产物,这些聚集体需要通过用变性剂重折叠进行进一步处理,而这一过程本身就可能导致聚集。使用一种模型折叠蛋白细胞色素C,我们展示了最终变性剂浓度的增加如何降低蛋白在重折叠过程中聚集的倾向。使用偏振荧光各向异性,我们展示了如何通过增加蛋白在重折叠过程中保持柔性的时间来降低聚集水平,这是通过稀释比例来介导的。这突出了蛋白的柔性与其聚集倾向之间的关系。我们将这种行为归因于尿素与残基之间的优先相互作用,而非分子间的自缔合。